Prediction of pharmacokinetic properties using experimental approaches during early drug discovery.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Current Opinion in Chemical Biology

• Publication date

  2001-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S1367-5931(00)00228-3PMID 11470610
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Estimating Human Oral Fraction Dose Absorbed: A Correlation Using Rat Intestinal Membrane Permeability for Passive and Carrier-Mediated Compounds

  2004cited by this paper
• The Madin Darby Canine Kidney (MDCK) Epithelial Cell Monolayer as a Model Cellular Transport Barrier

  2004cited by this paper
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

  2001cited by this paper
• Experimental and computational screening models for the prediction of intestinal drug absorption.

  2001cited by this paper
• Oral Drug Absorption: Prediction and Assessment

  2000cited by this paper
• Cell cultures as tools in biopharmacy.

  2000cited by this paper
• Intestinal Permeability: Prediction from Theory

  2000cited by this paper
• High-throughput screening in drug metabolism and pharmacokinetic support of drug discovery.

  2000cited by this paper
• In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs.

  2000cited by this paper
• Analysis of drug transport and metabolism in cell monolayer systems that have been modified by cytochrome P4503A4 cDNA-expression.

  2000cited by this paper
• A convenient in vitro screening method for predicting in vivo drug metabolic clearance using isolated hepatocytes suspended in serum.

  2000cited by this paper
• Drug-like properties and the causes of poor solubility and poor permeability.

  2000cited by this paper
• Chapter 27. Ex vivo approaches to predicting oral pharmacokinetics in humans

  2000cited by this paper
• Prediction of Membrane Permeability to Peptides from Calculated Dynamic Molecular Surface Properties

  1999cited by this paper
• Biliary excretion in primary rat hepatocytes cultured in a collagen-sandwich configuration.

  1999cited by this paper
• MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening.

  1999cited by this paper
• The use of heterologously expressed drug metabolizing enzymes--state of the art and prospects for the future.

  1999cited by this paper
• Gastrointestinal absorption of drugs: methods and studies

  1999cited by this paper
• Prediction of Hepatic Metabolic Clearance Based on Interspecies Allometric Scaling Techniques and In Vitro-In Vivo Correlations

  1999cited by this paper
• Pharmacokinetics and metabolism in early drug discovery.

  1999cited by this paper
• The fundamental variables of the biopharmaceutics classification system (BCS): a commentary.

  1998cited by this paper
• Applications and limitations of interspecies scaling and in vitro extrapolation in pharmacokinetics.

  1998cited by this paper
• Quantitative prediction of in vivo drug clearance and drug interactions from in vitro data on metabolism, together with binding and transport.

  1998cited by this paper
• Can we learn to distinguish between "drug-like" and "nondrug-like" molecules?

  1998cited by this paper
• The fundamental variables of the biopharmaceutics classification system (BCS): a commentary.

  1998cited by this paper
• Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes.

  1998cited by this paper
• Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans

  1997cited by this paper
• In Vitro Permeability Across Caco-2 Cells (Colonic) Can Predict In Vivo (Small Intestinal) Absorption in Man—Fact or Myth

  1997cited by this paper
• Scaling factors to relate drug metabolic clearance in hepatic microsomes, isolated hepatocytes, and the intact liver: studies with induced livers involving diazepam.

  1997cited by this paper
• Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract.

  1997cited by this paper
• Selection of development candidates based on in vitro permeability measurements

  1997cited by this paper
• Applications of the Caco-2 model in the design and development of orally active drugs: elucidation of biochemical and physical barriers posed by the intestinal epithelium

  1997cited by this paper
• The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data.

  1997cited by this paper
• PREDICTION OF IN VIVO DRUG DISPOSITION FROM IN VITRO DATA BASED ON PHYSIOLOGICAL PHARMACOKINETICS

  1996cited by this paper
• Interspecies scaling: predicting pharmacokinetic parameters of antiepileptic drugs in humans from animals with special emphasis on clearance.

  1996cited by this paper
• Cultured intestinal epithelial cell models.

  1996cited by this paper
• Comparison Between Permeability Coefficients in Rat and Human Jejunum

  1996cited by this paper
• Models for Assessing Drug Absorption and Metabolism

  1996cited by this paper
• Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo

  1996cited by this paper
• Design principles for orally bioavailable drugs

  1996cited by this paper
• Estimation of Caco‐2 Cell Permeability using Calculated Molecular Descriptors

  1996cited by this paper
• Species similarities and differences in pharmacokinetics.

  1995cited by this paper
• IAM chromatography: an in vitro screen for predicting drug membrane permeability.

  1995cited by this paper
• A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability

  1995cited by this paper
• Comparison of Intestinal Permeabilities Determined in Multiple in Vitro and inSitu Models: Relationship to Absorption in Humans

  1995cited by this paper
• Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance.

  1994cited by this paper
• Use of everted intestinal rings for in vitro examination of oral absorption potential.

  1994cited by this paper
• A Saturable Transport Mechanism in the Intestinal Absorption of Gabapentin Is the Underlying Cause of the Lack of Proportionality Between Increasing Dose and Drug Levels in Plasma

  1993cited by this paper
• A Correlation Between the Permeability Characteristics of a Series of Peptides Using an in Vitro Cell Culture Model (Caco-2) and Those Using an in Situ Perfused Rat Ileum Model of the Intestinal Mucosa

  1993cited by this paper
• Convective Solvent Flow Across the Skin During Iontophoresis

  1993cited by this paper
• Influence of D-glucose-induced water absorption on rat jejunal uptake of two passively absorbed drugs.

  1992cited by this paper
• Tissue Binding versus Plasma Binding of Drugs: General Principles and Pharmacokinetic Consequences

  1991cited by this paper
• Allometry as a tool for extrapolation of biological variables

  1991cited by this paper
• Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells.

  1991cited by this paper
• Transepithelial Transport of Aliphatic Carboxylic Acids Studied in Madin Darby Canine Kidney (MDCK) Cell Monolayers

  1990cited by this paper
• Pharmacokinetic evaluation in man of terbutaline given as separate enantiomers and as the racemate.

  1989cited by this paper
• Pharmacokinetics of the enantiomers of terbutaline after repeated oral dosing with racemic terbutaline.

  1989cited by this paper
• Carrier mediated transport of amino acids, small peptides, and their drug analogs

  1987cited by this paper
• Man versus beast: pharmacokinetic scaling in mammals.

  1986cited by this paper
• Absorption and metabolism of acetaminophen by the in situ perfused rat small intestine preparation.

  1986cited by this paper
• Correlation between in‐vitro microsomal enzyme activity and whole organ hepatic elimination kinetics: analysis with a dispersion model

  1986cited by this paper
• Absorption potential: estimating the fraction absorbed for orally administered compounds.

  1985cited by this paper
• Disposition of enalapril in the perfused rat intestine-liver preparation: absorption, metabolism and first-pass effect.

  1985cited by this paper
• Pharmacokinetic parameters of terbutaline in healthy man. An overview.

  1984cited by this paper
• Prediction of the disposition ofβ-lactam antibiotics in humans from pharmacokinetic parameters in animals

  1984cited by this paper
• Sequential organ first-pass effects: simple methods for constructing compartmental pharmacokinetic models from physiological models of drug disposition by several organs.

  1982cited by this paper
• Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics

  1982cited by this paper
• Comparative pharmacokinetics of benzodiazepines in dog and man

  1982cited by this paper
• Apparent volumes of distribution and drug binding to plasma proteins and tissues

  1978cited by this paper
• Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance.

  1977cited by this paper
• Animal scale-up

  1973cited by this paper
• Interspecies correlation of plasma concentration history of methotrexate (NSC-740).

  1970cited by this paper
• Advances in Drug Research

  1964cited by this paper

• Toxicological assessment of novel Anti-COVID traditional Chinese medicine formulae NRICM101 and NRICM102: a comprehensive study on safety and genotoxicity

  2025cites this paper
• Development and validation of a RP-HPLC method for simultaneous determination of cimetidine, metoprolol tartrate and phenol red for intestinal perfusion studies.

  2025cites this paper
• Effects of psychedelics on opioid use disorder: a scoping review of preclinical studies

  2025cites this paper
• Rational design, synthesis, and molecular modelling insights of dual DNA binders/DHFR inhibitors bearing arylidene-hydrazinyl-1,3-thiazole scaffold with apoptotic and anti-migratory potential in breast MCF-7 cancer cells

  2025cites this paper
• Simultaneously Predicting the Pharmacokinetics of CES1-Metabolized Drugs and Their Metabolites Using Physiologically Based Pharmacokinetic Model in Cirrhosis Subjects

  2024influential citation
• Identification of new 5-(2,6-dichlorophenyl)-3-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidine-7-carboxylic acids as p38α MAPK inhibitors: Design, synthesis, antitumor evaluation, molecular docking and in silico studies.

  2024cites this paper
• Biopharmaceutical studies of a novel sedative sublingual lozenge based on glycine and tryptophan: A rationale for mucoadhesive agent selection.

  2024cites this paper
• In silico identification of potential inhibitors of acyl carrier protein reductase and acetyl CoA carboxylase of Plasmodium falciparum in antimalarial therapy

  2023cites this paper
• Identification of novel scaffolds to inhibit Mycobacterium tuberculosis PimA protein—A computational approach

  2023cites this paper
• Halting aberrant DNA methylation via in silico Identification of potent inhibitors of DNMT3B enzyme: Atomistic insights

  2023cites this paper
• Novel potent azetidine-based compounds irreversibly inhibit Stat3 activation and induce antitumor response against human breast tumor growth in vivo

  2022cites this paper
• Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19

  2022cites this paper
• Molecular docking studies of potential inhibitors of acyl carrier protein and acetyl CoA Carboxylase in Plasmodium falciparum

  2022cites this paper
• Using in vitro ADME data for lead compound selection: An emphasis on PAMPA pH 5 permeability and oral bioavailability.

  2022cites this paper
• Importance of Hydrogen Bonding: Structure-Activity Relationships of Ruthenium(III) Complexes with Pyridine-Based Ligands for Alzheimer's Disease Therapy.

  2021cites this paper
• Computer-Aided Anticancer Drug Design: In vitro and In silico Studies of New Iminocoumarin Derivative

  2021cites this paper
• Advancements in Cancer Therapeutics

  2021cites this paper
• Systematic Review of Systemic and Neuraxial Effects of Acetaminophen in Preclinical Models of Nociceptive Processing

  2021cites this paper
• Identification of Terpenoids From Abrus precatorius Against Parkinson’s Disease Proteins Using In Silico Approach

  2021cites this paper
• Brønsted acid functionalized carbon catalyst for synthesis of biologically active coumarin-substituted bis(indolyl)methanes

  2021cites this paper
• Pharmacokinetic characterization of drugs and new product development

  2021cites this paper
• Prediction of Hepatic Drug Clearance with a Human Microfluidic Four-Cell Liver Acinus MicroPhysiology System.

  2021cites this paper
• Effects of Repeated Oral Administration of Esaxerenone on the Pharmacokinetics of Midazolam in Healthy Japanese Males

  2021cites this paper
• In Vitro ADME, Preclinical Pharmacokinetics and Prediction of Human Pharmacokinetics of RBx14255, a Novel Ketolide with Pharmacodynamics Against Multidrug-Resistant Bacterial Pathogens.

  2020cites this paper
• Intraperitoneal Administration of Telmisartan Prevents Postsurgical Adhesion Band Formation.

  2020cites this paper
• Discovery of Novel Azetidine Amides as Potent Small-Molecule STAT3 Inhibitors

  2020cites this paper
• The hidden hazardous effects of stevia and sucralose consumption in male and female albino mice in comparison to sucrose

  2020cites this paper
• A Guide for Estimating the Maximum Safe Starting Dose and Conversion it between Animals and Humans

  2020cites this paper
• Virtual Screening and Its Applications in Drug Discovery Process

  2019cites this paper
• Determining molecular properties with differential mobility spectrometry and machine learning

  2018cites this paper
• In Silico study of the active site of Helicobacter pylori urease and its inhibition by hydroxamic acids.

  2018cites this paper
• Computational modeling of human oral bioavailability: what will be next?

  2018cites this paper
• Computational tools in the assistance of personalized healthcare

  2018cites this paper
• Dose translation between laboratory animals and human in preclinical and clinical phases of drug development

  2018cites this paper
• Parallel screening of drug-like natural compounds using Caco-2 cell permeability QSAR model with applicability domain, lipophilic ligand efficiency index and shape property: A case study of HIV-1 reverse transcriptase inhibitors

  2017cites this paper
• Assessing Physicochemical Properties of Drug Molecules via Microsolvation Measurements with Differential Mobility Spectrometry

  2017cites this paper
• Treatment of Cyclosporin A retains host defense against invasive pulmonary aspergillosis in a non-immunosuppressive murine model by preserving the myeloid cell population

  2017cites this paper
• Bio-relevant characterisation of lipidic formulations and prediction of in vivo exposure

  2017cites this paper
• In silicoAcute Myeloid Leukaemia

  2017cites this paper
• Identification of small molecular ligands as potent inhibitors of fatty acid metabolism in Mycobacterium tuberculosis

  2017cites this paper
• High yield synthesis of cyclic analogues of antibacterial peptides P-113 by Sortase A-mediated ligation and their conformation studies

  2017cites this paper
• A simple practice guide for dose conversion between animals and human

  2016cites this paper
• Caracterização in vitro do metabolismo e da absorção intestinal da casearina X

  2016cites this paper
• New IVIVE method for the prediction of total human clearance and relative elimination pathway contributions from in vitro hepatocyte and microsome data.

  2016cites this paper
• Computational analysis reveal inhibitory action of nimbin against dengue viral envelope protein

  2015cites this paper
• Kinetics of the Absorption, Distribution, Metabolism, and Excretion of Lobeglitazone, a Novel Activator of Peroxisome Proliferator-Activated Receptor Gamma in Rats.

  2015cites this paper
• FimH antagonists: bioisosteres to improve the in vitro and in vivo PK/PD profile.

  2015cites this paper
• Drug metabolism and drug interactions: potential application to antituberculosis drugs.

  2015cites this paper
• The identification of lobeglitazone metabolites in rat liver microsomes and the kinetics of the in vivo formation of the major metabolite M1 in rats.

  2015cites this paper
• Characterization of Inhibitors of Fatty Acid Transport Protein-2 in Cell and Animal Models

  2015cites this paper
• Interaction studies of chiral non-steroidal anti-inflammatory drugs with HSA protein using capillary electrophoresis frontal analysis and electrokinetic chromatography

  2015cites this paper
• Membranes in Drug Delivery

  2015cites this paper
• Consequences of a lack of adult intravenous data on the prediction accuracy of pediatric physiologically based pharmacokinetic (PBPK) modeling

  2015cites this paper
• Gender differences in the hepatic elimination and pharmacokinetics of lobeglitazone in rats.

  2015cites this paper
• In Situ Single Pass Perfused Rat Intestinal Model

  2014cites this paper
• Applications of a 7-day Caco-2 cell model in drug discovery and development.

  2014cites this paper
• The development of gut hormones as drugs for the treatment of obesity

  2014cites this paper
• In vitro metabolism, disposition, preclinical pharmacokinetics and prediction of human pharmacokinetics of DNDI-VL-2098, a potential oral treatment for Visceral Leishmaniasis.

  2014cites this paper
• Chimeric rodents with humanized liver: bridging the preclinical/clinical trial gap in ADME/toxicity studies

  2014cites this paper
• Prediction of dose-hepatotoxic response in humans based on toxicokinetic/toxicodynamic modeling with or without in vivo data: a case study with acetaminophen.

  2013cites this paper
• Novel 3-nitro-1H-1,2,4-triazole-based compounds as potential anti-Chagasic drugs: in vivo studies.

  2013cites this paper
• Towards the virtual screening of BIK inhibitors with the homology-modeled protein structure

  2013cites this paper
• Rapid Screening of Drug-Protein Binding Using High-Performance Affinity Chromatography with Columns Containing Immobilized Human Serum Albumin

  2013cites this paper
• Preclinical evaluation of carbon-11 and fluorine-18 sulfonamide derivatives for in vivo radiolabeling of erythrocytes

  2013cites this paper
• Pharmacokinetic properties and in silico ADME modeling in drug discovery.

  2013cites this paper
• Model-Based Approaches to Characterize Clinical Pharmacokinetics of Atorvastatin and Rosuvastatin in Disease State

  2013cites this paper
• DEM simulation of drug release from structurally heterogeneous swelling tablets

  2013cites this paper
• ADME Profiling in Drug Discovery and Development: An Overview

  2012cites this paper
• Technical Challenges and Recent Advances of Implementing Comprehensive ADMET Tools in Drug Discovery

  2012cites this paper
• QSPR in oral bioavailability: specificity or integrality?

  2012cites this paper
• A ligand-based approach for enhancing the pharmacokinetic profile of highly charged antibacterial agents

  2012influential citation
• QSAR Prediction of Passive Permeability in the LLC‐PK1 Cell Line: Trends in Molecular Properties and Cross‐Prediction of Caco‐2 Permeabilities

  2012cites this paper
• Effects of C7 substitutions in a high affinity microtubule-binding taxane on antitumor activity and drug transport.

  2011cites this paper
• QSAR-based permeability model for drug-like compounds.

  2011cites this paper
• Investigating the barriers to bioavailability of macrolide antibiotics in the rat

  2011cites this paper
• Quantitative in Vitro ADME Assays Using LC–MS as a Part of Early Drug Metabolism Screening

  2011cites this paper
• Insilico studies of organosulfur‐functional active compounds in garlic

  2010cites this paper
• Estimation of Human Starting Dose for Phase I Clinical Programs

  2010cites this paper
• Use of intrinsic clearance for prediction of human hepatic clearance

  2010cites this paper
• Toxicokinetics: An Integral Component of Preclinical Toxicity Studies

  2010cites this paper
• Prediction of human hepatic clearance using an in vitro plated hepatocyte clearance model.

  2009cites this paper
• The Drug Discovery Process: From Molecules to Drugs

  2009cites this paper
• Advances in the integration of drug metabolism into the lead optimization paradigm.

  2009cites this paper
• Modeling Kinetics of Subcellular Disposition of Chemicals

  2009cites this paper
• Design and application of microfluidic systems for in vitro pharmacokinetic evaluation of drug candidates.

  2009cites this paper
• Prediction of distribution of neutral, acidic and basic structurally diverse compounds between blood and brain by the nonlinear methodology.

  2008cites this paper
• UNIVERSIDADE DE SÃO PAULO INSTITUTO DE FÍSICA DE SÃO CARLOS

  2008cites this paper
• Handbook of Membrane Separations Chemical, Pharmaceutical, Food, and Biotechnological Applications

  2008influential citation
• Development of In Vitro Pharmacokinetic Screens Using Caco-2, Human Hepatocyte, and Caco-2/Human Hepatocyte Hybrid Systems for the Prediction of Oral Bioavailability in Humans

  2007cites this paper
• Kinetic determinants of hepatic clearance: Plasma protein binding and hepatic uptake

  2007influential citation
• In vitro–in vivo extrapolation of hepatic clearance: Biological tools, scaling factors, model assumptions and correct concentrations

  2007cites this paper
• Modelos in vitro para determinação da absorção de fármacos e previsão da relação dissolução/absorção

  2007cites this paper
• Lead Optimization in Discovery Drug Metabolism and Pharmacokinetics/Case study: The Hepatitis C Virus (HCV) Protease Inhibitor SCH 503034

  2007cites this paper
• A comparison of physicochemical property profiles of marketed oral drugs and orally bioavailable anti-cancer protein kinase inhibitors in clinical development.

  2007cites this paper
• Drug Targeting of α-Synuclein Oligomerization in Synucleinopathies

  2007cites this paper
• Mass Spectrometry in Early Pharmacokinetic Investigations

  2007cites this paper
• In Silico ADME Modeling 3: Computational Models to Predict Human Intestinal Absorption Using Sphere Exclusion and kNN QSAR Methods

  2007cites this paper
• Estimation of ADME properties in drug discovery: predicting Caco-2 cell permeability using atom-based stochastic and non-stochastic linear indices.

  2007cites this paper
• In silico ADME modelling 2: computational models to predict human serum albumin binding affinity using ant colony systems.

  2006cites this paper
• Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.

  2006cites this paper